California Nanotechnologies Balance Sheet Health
Financial Health criteria checks 6/6
California Nanotechnologies has a total shareholder equity of $388.7K and total debt of $1.1M, which brings its debt-to-equity ratio to 282.7%. Its total assets and total liabilities are $2.6M and $2.3M respectively. California Nanotechnologies's EBIT is $642.1K making its interest coverage ratio 6.5. It has cash and short-term investments of $1.1M.
Key information
282.7%
Debt to equity ratio
US$1.10m
Debt
| Interest coverage ratio | 6.5x |
| Cash | US$1.13m |
| Equity | US$388.69k |
| Total liabilities | US$2.26m |
| Total assets | US$2.64m |
Recent financial health updates
Recent updates
California Nanotechnologies Corp.'s (CVE:CNO) Shares Climb 32% But Its Business Is Yet to Catch Up
Apr 07
Earnings Not Telling The Story For California Nanotechnologies Corp. (CVE:CNO) After Shares Rise 29%
Jan 25Should You Be Adding California Nanotechnologies (CVE:CNO) To Your Watchlist Today?
Jan 17Subdued Growth No Barrier To California Nanotechnologies Corp.'s (CVE:CNO) Price
Jun 30Financial Position Analysis
Short Term Liabilities: CNO's short term assets ($2.0M) exceed its short term liabilities ($402.0K).
Long Term Liabilities: CNO's short term assets ($2.0M) exceed its long term liabilities ($1.9M).
Debt to Equity History and Analysis
Debt Level: CNO has more cash than its total debt.
Reducing Debt: CNO had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: CNO's debt is well covered by operating cash flow (35.8%).
Interest Coverage: CNO's interest payments on its debt are well covered by EBIT (6.5x coverage).